| First Author | Aicart-Ramos C | Year | 2014 |
| Journal | J Cell Sci | Volume | 127 |
| Issue | Pt 15 | Pages | 3360-72 |
| PubMed ID | 24928905 | Mgi Jnum | J:216242 |
| Mgi Id | MGI:5608549 | Doi | 10.1242/jcs.148601 |
| Citation | Aicart-Ramos C, et al. (2014) Protein kinase D activity controls endothelial nitric oxide synthesis. J Cell Sci 127(Pt 15):3360-72 |
| abstractText | Vascular endothelial growth factor (VEGF) regulates key functions of the endothelium, such as angiogenesis or vessel repair in processes involving endothelial nitric oxide synthase (eNOS) activation. One of the effector kinases that become activated in endothelial cells upon VEGF treatment is protein kinase D (PKD). Here, we show that PKD phosphorylates eNOS, leading to its activation and a concomitant increase in NO synthesis. Using mass spectrometry, we show that the purified active kinase specifically phosphorylates recombinant eNOS on Ser1179. Treatment of endothelial cells with VEGF or phorbol 12,13-dibutyrate (PDBu) activates PKD and increases eNOS Ser1179 phosphorylation. In addition, pharmacological inhibition of PKD and gene silencing of both PKD1 and PKD2 abrogate VEGF signaling, resulting in a clear diminished migration of endothelial cells in a wound healing assay. Finally, inhibition of PKD in mice results in an almost complete disappearance of the VEGF-induced vasodilatation, as monitored through determination of the diameter of the carotid artery. Hence, our data indicate that PKD is a new regulatory kinase of eNOS in endothelial cells whose activity orchestrates mammalian vascular tone. |
